Free Trial

Revvity (RVTY) Competitors

Revvity logo
$95.69 -0.38 (-0.40%)
As of 06/12/2025 03:58 PM Eastern

RVTY vs. KEYS, VLTO, FTV, TER, AVTR, BIO.B, NVMI, VNT, MIR, and ST

Should you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Keysight Technologies (KEYS), Veralto (VLTO), Fortive (FTV), Teradyne (TER), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Vontier (VNT), Mirion Technologies (MIR), and Sensata Technologies (ST). These companies are all part of the "measuring and control equipment" industry.

Revvity vs. Its Competitors

Revvity (NYSE:RVTY) and Keysight Technologies (NYSE:KEYS) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations, community ranking and risk.

Revvity presently has a consensus price target of $125.64, indicating a potential upside of 31.30%. Keysight Technologies has a consensus price target of $183.00, indicating a potential upside of 13.06%. Given Revvity's stronger consensus rating and higher probable upside, analysts clearly believe Revvity is more favorable than Keysight Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revvity
0 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.80
Keysight Technologies
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.78

In the previous week, Keysight Technologies had 9 more articles in the media than Revvity. MarketBeat recorded 10 mentions for Keysight Technologies and 1 mentions for Revvity. Revvity's average media sentiment score of 1.69 beat Keysight Technologies' score of 0.78 indicating that Revvity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revvity
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Keysight Technologies
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

86.7% of Revvity shares are owned by institutional investors. Comparatively, 84.6% of Keysight Technologies shares are owned by institutional investors. 0.7% of Revvity shares are owned by insiders. Comparatively, 0.6% of Keysight Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Keysight Technologies has higher revenue and earnings than Revvity. Keysight Technologies is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revvity$2.77B4.07$270.39M$2.3540.72
Keysight Technologies$5.11B5.45$614M$4.2638.00

Keysight Technologies has a net margin of 12.32% compared to Revvity's net margin of 9.81%. Keysight Technologies' return on equity of 19.22% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Revvity9.81% 7.68% 4.62%
Keysight Technologies 12.32%19.22%10.52%

Revvity has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, Keysight Technologies has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500.

Keysight Technologies received 449 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 66.30% of users gave Keysight Technologies an outperform vote while only 62.50% of users gave Revvity an outperform vote.

CompanyUnderperformOutperform
RevvityOutperform Votes
35
62.50%
Underperform Votes
21
37.50%
Keysight TechnologiesOutperform Votes
484
66.30%
Underperform Votes
246
33.70%

Summary

Keysight Technologies beats Revvity on 12 of the 19 factors compared between the two stocks.

Get Revvity News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVTY vs. The Competition

MetricRevvityAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$11.28B$4.58B$5.61B$19.88B
Dividend Yield0.31%0.55%5.28%3.83%
P/E Ratio43.3028.5927.2135.60
Price / Sales4.074.02408.4943.81
Price / Cash13.4736.3338.2517.51
Price / Book1.521.667.074.85
Net Income$270.39M-$84.30M$3.23B$1.02B
7 Day Performance4.02%2.46%0.68%0.90%
1 Month Performance-1.51%9.88%9.59%2.35%
1 Year Performance-13.57%-9.82%32.02%10.79%

Revvity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVTY
Revvity
3.9691 of 5 stars
$95.69
-0.4%
$125.64
+31.3%
-15.0%$11.28B$2.77B43.3016,700Positive News
KEYS
Keysight Technologies
4.2338 of 5 stars
$158.36
+0.8%
$183.00
+15.6%
+17.2%$27.37B$5.11B45.2515,000Analyst Revision
VLTO
Veralto
4.2011 of 5 stars
$100.28
-0.7%
$110.09
+9.8%
-2.4%$24.86B$5.28B30.0216,000Positive News
FTV
Fortive
4.7679 of 5 stars
$70.24
+0.1%
$81.92
+16.6%
-4.0%$23.87B$6.18B29.7618,000
TER
Teradyne
4.8411 of 5 stars
$79.49
+1.1%
$114.67
+44.3%
-42.3%$12.75B$2.91B23.876,500Positive News
Analyst Revision
AVTR
Avantor
4.7896 of 5 stars
$12.96
+0.4%
$18.88
+45.6%
-38.8%$8.83B$6.69B12.4614,500Positive News
Short Interest ↑
BIO.B
Bio-Rad Laboratories
N/A$250.08
flat
N/A-13.3%$7.00B$2.54B-3.858,200
NVMI
Nova
1.987 of 5 stars
$211.80
-0.9%
$277.00
+30.8%
-2.7%$6.23B$743.95M36.901,180Positive News
Analyst Revision
Gap Down
VNT
Vontier
3.4243 of 5 stars
$35.63
-0.3%
$44.83
+25.8%
-6.2%$5.27B$2.96B12.968,100Positive News
MIR
Mirion Technologies
0.695 of 5 stars
$19.25
+0.8%
$18.75
-2.6%
+100.6%$4.46B$870.20M-101.292,870Short Interest ↑
ST
Sensata Technologies
4.8167 of 5 stars
$25.71
-1.3%
$34.08
+32.6%
-27.5%$3.76B$3.84B30.6120,800

Related Companies and Tools


This page (NYSE:RVTY) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners